NeOnc Technologies Holdings Overview
- Year Founded
-
2008
- Status
-
Public
- Employees
-
5
- Stock Symbol
-
NTHI
- Investments
-
2
- Share Price
-
$3.50
- (As of Thursday Closing)
NeOnc Technologies Holdings General Information
Description
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.
Contact Information
Website
www.neonc.comCorporate Office
- 23975 Park Sorrento
- Suite 205
- Calabasas, CA 91302
- United States
Corporate Office
- 23975 Park Sorrento
- Suite 205
- Calabasas, CA 91302
- United States
NeOnc Technologies Holdings Timeline
NeOnc Technologies Holdings Stock Performance
As of 19-Nov-2026, NeOnc Technologies Holdings’s stock price is $3.50. Its current market cap is $100M with 28.9M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.50 | $4.14 | $2.50 - $11.38 | $100M | 28.9M | 186K | -$1.95 |
NeOnc Technologies Holdings Financials Summary
As of 30-Sep-2026, NeOnc Technologies Holdings has a trailing 12-month revenue of $40K.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 96,437 | 201,805 | ||
| Revenue | 40 | 40 | 83 | 70 |
| EBITDA | (40,371) | (59,933) | (9,112) | (12,198) |
| Net Income | (43,024) | (62,146) | (11,898) | (14,921) |
| Total Assets | 9,304 | 2,824 | 3,417 | 1,265 |
| Total Debt | 310 | 6,314 | 25 | 6,605 |
NeOnc Technologies Holdings Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
NeOnc Technologies Holdings Patents
NeOnc Technologies Holdings Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240216293-A1 | Use of perillyl alcohol to enhance levo-dopa delivery | Pending | 28-Apr-2021 | ||
| WO-2022232347-A1 | Use of perillyl alcohol to enhance levo-dopa delivery | Inactive | 28-Apr-2021 | ||
| WO-2022221759-A1 | Pharmaceutical compositions comprising poh derivatives | Inactive | 16-Apr-2021 | ||
| EP-4243794-A1 | Treatment of recurrent gioblastoma with perillyl alcohol | Pending | 12-Nov-2020 | ||
| EP-4243794-A4 | Treatment of recurrent gioblastoma with perillyl alcohol | Pending | 12-Nov-2020 | A61K47/10 |
NeOnc Technologies Holdings Signals
NeOnc Technologies Holdings Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
NeOnc Technologies Holdings Investments & Acquisitions (2)
NeOnc Technologies Holdings’s most recent deal was a Corporate Asset Purchase with NeOnc Technologies (Portfolio of Advanced AI, 3D Bioprinting, and Quantum Modeling Technologies) for . The deal was made on 25-Aug-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| NeOnc Technologies (Portfolio of Advanced AI, 3D Bioprinting, and Quantum Modeling Technologies) | 25-Aug-2025 | Corporate Asset Purchase | Buildings and Property | ||
| JandB Holdings | 18-Aug-2025 | Merger/Acquisition | Other Commercial Products |
NeOnc Technologies Holdings ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
NeOnc Technologies Holdings FAQs
-
When was NeOnc Technologies Holdings founded?
NeOnc Technologies Holdings was founded in 2008.
-
Where is NeOnc Technologies Holdings headquartered?
NeOnc Technologies Holdings is headquartered in Calabasas, CA.
-
What is the size of NeOnc Technologies Holdings?
NeOnc Technologies Holdings has 5 total employees.
-
What industry is NeOnc Technologies Holdings in?
NeOnc Technologies Holdings’s primary industry is Drug Discovery.
-
Is NeOnc Technologies Holdings a private or public company?
NeOnc Technologies Holdings is a Public company.
-
What is NeOnc Technologies Holdings’s stock symbol?
The ticker symbol for NeOnc Technologies Holdings is NTHI.
-
What is the current stock price of NeOnc Technologies Holdings?
As of 19-Nov-2026 the stock price of NeOnc Technologies Holdings is $3.50.
-
What is the current market cap of NeOnc Technologies Holdings?
The current market capitalization of NeOnc Technologies Holdings is $100M.
-
What is NeOnc Technologies Holdings’s current revenue?
The trailing twelve month revenue for NeOnc Technologies Holdings is $40K.
-
What is NeOnc Technologies Holdings’s annual earnings per share (EPS)?
NeOnc Technologies Holdings’s EPS for 12 months was -$1.95.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process